TPI Fund Managers’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-58,064
Closed -$7.28M 42
2020
Q4
$7.28M Buy
58,064
+4,583
+9% +$513K 1.25% 34
2020
Q3
$5.42M Buy
53,481
+920
+2% +$93.8K 1.16% 36
2020
Q2
$5.11M Buy
52,561
+5,315
+11% +$495K 1.19% 32
2020
Q1
$3.92M Buy
47,246
+281
+0.6% +$27.4K 1.19% 31
2019
Q4
$5.22M Buy
46,965
+9,414
+25% +$968K 1.26% 32
2019
Q3
$3.73M Buy
37,551
+1,687
+5% +$168K 1.06% 33
2019
Q2
$3.56M Buy
+35,864
New +$3.42M 1.09% 32

Other funds holding PRAH

TPI Fund Managers's PRAH Position: Q1 2021 in Review

TPI Fund Managers sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 58,064 shares — an estimated $7.28M sold.

TPI Fund Managers first reported a position in PRAH in Q2 2019 and held it in 7 quarters. The position peaked at $7.28M in Q4 2020. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • TPI Fund Managers reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • TPI Fund Managers sold 58,064 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $7.28M.
  • TPI Fund Managers first reported a position in PRA Health Sciences, Inc. in Q2 2019 and held it in 7 quarters.
  • TPI Fund Managers's PRA Health Sciences, Inc. position peaked at $7.28M in Q4 2020.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on TPI Fund Managers's 13F filing for Q1 2021, filed 11 May 2021.